2022-501183-17-00CompletedPhase 1/2
First-in-human phase I/IIa study investigating inhaled CIS-DPI as add-on treatment in Stage IV NSCLC patients
Source: EU CTIS (euclinicaltrials.eu) · Last updated 24 Jul 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 64 (actual)
- First submitted
- 17 Sept 2022
- Start date
- 23 Feb 2023
- Lead sponsor
- Inhatarget Therapeutics
- Diseases
- Lung cancer
- EU CT number
- 2022-501183-17-00
What you commit to
- Study type: Interventional · Phase 1/2
- Participants enrolled: 64
- 17 sites in 3 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (17)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institut Jules Bordet | Brussels | Belgium | Completed |
| Grand Hopital de Charleroi | Charleroi | Belgium | Completed |
| Algemeen Ziekenhuis Groeninge | Kortrijk | Belgium | Completed |
| Chu Helora | La Louvière | Belgium | Completed |
| CHU de Liège | Liège | Belgium | Completed |
| CHU Ambroise Paré | Mons | Belgium | Completed |
| AZ Delta | Roeselare | Belgium | Completed |
| Hospital Universitari Dexeus Grupo Quironsalud | Barcelona | Spain | Completed |
| Hospital Universitario La Paz | Madrid | Spain | Completed |
| Hospital Universitario 12 de Octubre | Madrid | Spain | Completed |
| University Hospital Virgen Del Rocio S.L. | Sevilla | Spain | Completed |
| Hôpital Ambroise-Paré | Boulogne-Billancourt | France | Completed |
| Centre Francois Baclesse | Caen Cedex 5 | France | Completed |
| Hopital Européen George Pompidou | Paris | France | Completed |
| Centre Hospitalier Universitaire de Poitiers | Poitiers | France | Completed |
| Centre Hospitalier Universitaire de Rennes | Rennes | France | Completed |
| Institut De Cancerologie De L Ouest | Saint-Herblain Cedex | France | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.